Literature DB >> 20922832

Imaging: PET is prognostic of survival in pancreatic cancer patients.

Lisa Hutchinson.   

Abstract

Entities:  

Year:  2010        PMID： 20922832     DOI： 10.1038/nrclinonc.2010.150

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy.

Authors:  Devin Schellenberg; Andy Quon; A Yuriko Minn; Edward E Graves; Pamela Kunz; James M Ford; George A Fisher; Karyn A Goodman; Albert C Koong; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-07       Impact factor: 7.038
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.